Autologous Expertise Progencell specializes in autologous stem cell therapies using the patient’s own bone marrow cells, presenting a unique value proposition for patients seeking regenerative solutions with reduced rejection risk.

Small to Mid-Cap Focus With 11-50 employees and revenue in the 0-1M range, Progencell targets a boutique, high-touch model that can be scaled through partnerships with clinics, wellness centers, and concierge medical practices to broaden patient access.

Wellness Market Position Operating in wellness and fitness services, there are cross-sell opportunities with complementary therapies, lifestyle programs, and preventative care services to build a broader, recurring revenue footprint.

Tech & Visibility Leverage digital marketing and patient education channels (YouTube, Facebook, Google Tag Manager, contact forms) to drive inquiries, appointments, and patient referrals while safeguarding regulatory communications.

Geographic Advantage Based in Tijuana, Mexico, there is potential to attract cross-border patients from the U.S. and Latin America seeking stem cell therapies, supported by strategic partnerships with local clinics and international patient facilitators.